HO-1 expression correlates with cancer growth and resistance to therapy as shown in different types of tumors, such as human renal cell carcinoma [26], prostate and pancreatic cancers [27, 28], melanoma [29], and hepatoma [30]. The gene discussed is HMOX1; the disease is renal cell carcinoma.